These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 14642736)

  • 1. Biotransformation of tamoxifen in a human endometrial explant culture model.
    Sharma M; Shubert DE; Sharma M; Lewis J; McGarrigle BP; Bofinger DP; Olson JR
    Chem Biol Interact; 2003 Dec; 146(3):237-49. PubMed ID: 14642736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidant inhibits tamoxifen-DNA adducts in endometrial explant culture.
    Sharma M; Shubert DE; Sharma M; Rodabaugh KJ; McGarrigle BP; Vezina CM; Bofinger DP; Olson JR
    Biochem Biophys Res Commun; 2003 Jul; 307(1):157-64. PubMed ID: 12849995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the human cytochrome P450 forms involved in metabolism of tamoxifen to its alpha-hydroxy and alpha,4-dihydroxy derivatives.
    Notley LM; Crewe KH; Taylor PJ; Lennard MS; Gillam EM
    Chem Res Toxicol; 2005 Oct; 18(10):1611-8. PubMed ID: 16533026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of tamoxifen by recombinant human cytochrome P450 enzymes: formation of the 4-hydroxy, 4'-hydroxy and N-desmethyl metabolites and isomerization of trans-4-hydroxytamoxifen.
    Crewe HK; Notley LM; Wunsch RM; Lennard MS; Gillam EM
    Drug Metab Dispos; 2002 Aug; 30(8):869-74. PubMed ID: 12124303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochrome P-450 3A and 2D6 catalyze ortho hydroxylation of 4-hydroxytamoxifen and 3-hydroxytamoxifen (droloxifene) yielding tamoxifen catechol: involvement of catechols in covalent binding to hepatic proteins.
    Dehal SS; Kupfer D
    Drug Metab Dispos; 1999 Jun; 27(6):681-8. PubMed ID: 10348797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of tamoxifen-DNA adducts in human endometrial explants exposed to alpha-hydroxytamoxifen.
    Kim SY; Suzuki N; Laxmi YR; McGarrigle BP; Olson JR; Sharma M; Sharma M; Shibutani S
    Chem Res Toxicol; 2005 May; 18(5):889-95. PubMed ID: 15892583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organ specificity of DNA adduct formation by tamoxifen and alpha-hydroxytamoxifen in the rat: implications for understanding the mechanism(s) of tamoxifen carcinogenicity and for human risk assessment.
    Phillips DH; Hewer A; Osborne MR; Cole KJ; Churchill C; Arlt VM
    Mutagenesis; 2005 Jul; 20(4):297-303. PubMed ID: 15928012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-hydroxylation of tamoxifen and toremifene by human and rat cytochrome P450 3A subfamily enzymes.
    Kim SY; Suzuki N; Santosh Laxmi YR; Rieger R; Shibutani S
    Chem Res Toxicol; 2003 Sep; 16(9):1138-44. PubMed ID: 12971802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen-induced adduct formation and cell stress in human endometrial glands.
    Andersson H; Helmestam M; Zebrowska A; Olovsson M; Brittebo E
    Drug Metab Dispos; 2010 Jan; 38(1):200-7. PubMed ID: 19812351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The formation of estrogen-like tamoxifen metabolites and their influence on enzyme activity and gene expression of ADME genes.
    Johänning J; Kröner P; Thomas M; Zanger UM; Nörenberg A; Eichelbaum M; Schwab M; Brauch H; Schroth W; Mürdter TE
    Arch Toxicol; 2018 Mar; 92(3):1099-1112. PubMed ID: 29285606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotoxicity of tamoxifen, tamoxifen epoxide and toremifene in human lymphoblastoid cells containing human cytochrome P450s.
    Styles JA; Davies A; Lim CK; De Matteis F; Stanley LA; White IN; Yuan ZX; Smith LL
    Carcinogenesis; 1994 Jan; 15(1):5-9. PubMed ID: 8293548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of tamoxifen-DNA adducts induced by alpha-acetoxy-N-desmethyltamoxifen.
    Kitagawa M; Ravindernath A; Suzuki N; Rieger R; Terashima I; Umemoto A; Shibutani S
    Chem Res Toxicol; 2000 Aug; 13(8):761-9. PubMed ID: 10956064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of TCDD exposure on CYP1A1 and CYP1B1 expression in explant cultures of human endometrium.
    Bofinger DP; Feng L; Chi LH; Love J; Stephen FD; Sutter TR; Osteen KG; Costich TG; Batt RE; Koury ST; Olson JR
    Toxicol Sci; 2001 Aug; 62(2):299-314. PubMed ID: 11452143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of human CYP forms involved in the activation of tamoxifen and irreversible binding to DNA.
    Boocock DJ; Brown K; Gibbs AH; Sanchez E; Turteltaub KW; White IN
    Carcinogenesis; 2002 Nov; 23(11):1897-901. PubMed ID: 12419838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ellipticine oxidation and DNA adduct formation in human hepatocytes is catalyzed by human cytochromes P450 and enhanced by cytochrome b5.
    Stiborová M; Poljaková J; Martínková E; Ulrichová J; Simánek V; Dvořák Z; Frei E
    Toxicology; 2012 Dec; 302(2-3):233-41. PubMed ID: 22917556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable contribution of cytochromes P450 2D6, 2C9 and 3A4 to the 4-hydroxylation of tamoxifen by human liver microsomes.
    Crewe HK; Ellis SW; Lennard MS; Tucker GT
    Biochem Pharmacol; 1997 Jan; 53(2):171-8. PubMed ID: 9037249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cytochrome P450 genes encoding enzymes active in the metabolism of tamoxifen in human uterine endometrium.
    Hukkanen J; Mäntylä M; Kangas L; Wirta P; Hakkola J; Paakki P; Evisalmi S; Pelkonen O; Raunio H
    Pharmacol Toxicol; 1998 Feb; 82(2):93-7. PubMed ID: 9498238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-hydroxytamoxifen, a genotoxic metabolite of tamoxifen in the rat: identification and quantification in vivo and in vitro.
    Boocock DJ; Maggs JL; White IN; Park BK
    Carcinogenesis; 1999 Jan; 20(1):153-60. PubMed ID: 9934863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major inter-species differences in the rates of O-sulphonation and O-glucuronylation of alpha-hydroxytamoxifen in vitro: a metabolic disparity protecting human liver from the formation of tamoxifen-DNA adducts.
    Boocock DJ; Maggs JL; Brown K; White IN; Park BK
    Carcinogenesis; 2000 Oct; 21(10):1851-8. PubMed ID: 11023543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of tamoxifen and its metabolite alpha-hydroxytamoxifen to DNA-binding products: comparisons between human, rat and mouse hepatocytes.
    Phillips DH; Carmichael PL; Hewer A; Cole KJ; Hardcastle IR; Poon GK; Keogh A; Strain AJ
    Carcinogenesis; 1996 Jan; 17(1):89-94. PubMed ID: 8565142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.